###begin article-title 0
MiR-92b and miR-9/9* Are Specifically Expressed in Brain Primary Tumors and Can Be Used to Differentiate Primary from Metastatic Brain Tumors
###end article-title 0
###begin p 1
These authors contributed equally to this work.
###end p 1
###begin p 2
These two principal investigators equally supervised the work.
###end p 2
###begin p 3
A recurring challenge for brain pathologists is to diagnose whether a brain malignancy is a primary tumor or a metastasis from some other tissue. The accurate diagnosis of brain malignancies is essential for selection of proper treatment. MicroRNAs are a class of small non-coding RNA species that regulate gene expression; many exhibit tissue-specific expression and are misregulated in cancer. Using microRNA expression profiling, we found that hsa-miR-92b and hsa-miR-9/hsa-miR-9* are over-expressed, specifically in brain primary tumors, as compared to primary tumors from other tissues and their metastases to the brain. By considering the expression of only these two microRNAs, it is possible to distinguish between primary and metastatic brain tumors with very high accuracy. These microRNAs thus represent excellent biomarkers for brain primary tumors. Previous reports have found that hsa-miR-92b and hsa-miR-9/hsa-miR-9* are expressed more strongly in developing neurons and brain than in adult brain. Thus, their specific over-expression in brain primary tumors supports a functional role for these microRNAs or a link between neuronal stem cells and brain tumorigenesis.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 723 727 723 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">(27)</xref>
###xml 791 792 791 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 794 795 794 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 797 799 797 799 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 1007 1010 1007 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
A current effort of cancer research is to discover biomarkers that can improve cancer diagnosis in a clinical setting. Specifically, the pathological characterization of brain malignancies remains a diagnostic challenge. Despite the advent of various high throughput genomic-level technologies, which allow multiple DNA sequences, mRNAs or proteins to be evaluated simultaneously and systematically, these have had little impact on clinical procedures. Recently, however, there has been a paradigm shift in our understanding of genome expression, with the realization that there exists a class of small non-coding RNA species, known as microRNAs (miRNAs or miRs), which have critical functions in many biological processes (27). Although the total number of microRNAs remains controversial (2, 3, 18) and the roles of specific microRNAs are only beginning to be defined, high throughput microRNA expression analyses indicate that these species represent promising candidates for clinical tumor cell markers (6).
###end p 5
###begin p 6
###xml 593 597 593 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">(27)</xref>
###xml 940 943 940 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b6">(6)</xref>
###xml 1095 1099 1083 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">(15)</xref>
###xml 1189 1193 1177 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">(11)</xref>
###xml 1369 1373 1357 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">(23)</xref>
###xml 1081 1086 <span type="species:ncbi:9606">human</span>
In general, microRNAs are regulated and transcribed similarly to protein coding genes. Subsequent microRNA biogenesis involves discrete processing and transport steps, whereby the active moiety of 20-22 nucleotides is excised from a longer RNA precursor that exhibits specific hairpin structure. Finally, these 20-22 nucleotides are incorporated into a composite machinery, termed the RNA-induced silencing complex, which promotes partial duplex formation between the short RNA and the 3' untranslated regions of targeted transcripts, resulting typically in mammals in translational silencing (27). Systematic, high throughput microRNA expression analyses of many diverse tumors indicate that tumors display microRNA expression profiles that are significantly different from those of normal tissue, and moreover, these microRNA profiles are extremely informative with respect to developmental lineage and differentiation state of the tumor (6). Studies have suggested that, unlike with mRNA expression, a modest number of approximately200 microRNAs might be sufficient to classify human cancers (15). According to emerging studies that reveal an unexpected target specificity of microRNAs (11), we set out to investigate whether a much smaller number of microRNAs may serve to identify tumors and to define clinically important tumor characteristics. In a recent study (23), we used microRNA microarray data and developed general classification algorithms for a range of tissues. In that study, we also identified microRNAs that can identify brain tumors from a subset of non-epithelial tumors.
###end p 6
###begin p 7
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">(10)</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">(30)</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b5">5</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 483 487 483 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">(26)</xref>
###xml 571 575 571 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">(19)</xref>
###xml 757 761 757 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">(19)</xref>
###xml 523 531 <span type="species:ncbi:9606">patients</span>
###xml 651 659 <span type="species:ncbi:9606">patients</span>
Differentiation between primary and metastatic tumors in the brain is often encountered in pathological practice, as metastatic tumors to the brain are quite frequent. The most common tumors to metastasize to the brain originate in the lung(10), breast (30) and skin (melanomas) (5, 7, 22); their respective contributions to all central nervous system (CNS) metastases are 30%, 20% and 10%. Although rare, choriocarcinoma disseminates to the brain with a particularly high frequency (26). In autopsy studies, 24% of cancer patients exhibited metastatic tumors in the CNS (19). Indeed, surgical pathologists are regularly presented with specimens from patients with a history of systemic neoplasia but with findings that suggest a primary intracranial tumor (19).
###end p 7
###begin p 8
###xml 939 943 939 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">(33)</xref>
###xml 1291 1293 1291 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 1295 1297 1295 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 1299 1301 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 1303 1305 1303 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 1472 1473 1472 1473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 1475 1477 1475 1477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 1257 1262 <span type="species:ncbi:9606">human</span>
Here, we directly compare brain tumors to a wide range of epithelial tumors and metastases to the brain. Using microarray data, we found that elevated expression of just two microRNAs, hsa-miR-92b and hsa-miR-9*, is sufficient to distinguish brain primary tumors from tumors derived from non-brain tissues, and most significantly for diagnostic purposes, from metastases located in the brain. We translated this assay to a qRT-PCR platform, using additional samples as a training set to develop a classifier. Validating on an independent set of test samples, we found that the simple combination of hsa-miR-92b and hsa-miR-9 (or hsa-miR-9*) can identify brain metastases from brain primary tumors with sensitivity of 88% and specificity of 100%. Thus, economical and relatively easy evaluation of hsa-miR-92b and hsa-miR-9/9* expression, which can be performed robustly using either fresh frozen or fixed materials in the clinical setting (33), reveals whether neoplastic tissue excised from the brain is brain-derived or represents a metastasis from another tissue. Hsa-miR-92b and hsa-miR-9/9* were identified previously to be over-expressed in developing brain and neuronal stem cells compared to adult brain, and thus have been implicated as players in human nervous system development (12, 13, 32, 34). Taken together, the expression data concerning hsa-miR-92b and hsa-miR-9/9* suggest a connection between deregulation of microRNAs, pluripotency and tumorigenesis (4, 31).
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Tumor samples
###end title 10
###begin p 11
###xml 918 925 916 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 950 958 948 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">Table S1</xref>
###xml 963 971 961 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD3">Table S2</xref>
A total of 285 formalin-fixed paraffin-embedded (FFPE) tumor samples were obtained from several sources (Sheba Medical Center, Tel-Hashomer, Israel; Soroka University Medical Center, Beer-Sheva, Israel; Beilinson Hospital, Rabin Medical Center, Petah-Tikva, Israel; ABS Inc., Wilmington, DE; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel). The study protocol was approved by the Research Ethics Board of each of the contributing institutes. Each of the FFPE samples was evaluated by a pathologist for histological type, grade and tumor percentage based on hematoxylin-eosin-stained slides, performed on the first and/or last sections of the sample. The tumor content was >/=50% in 92% of the samples. A total of 252 of the samples were profiled by microRNA microarray. Fourteen of these samples and 33 additional samples were profiled by qRT-PCR. Histological classification of the study samples is summarized in Table 1 and listed in detail in Table S1 and Table S2 in Supplementary Information online.
###end p 11
###begin p 12
Summary of samples. Abbreviation: BPH = Benign prostatic hyperplasia.
###end p 12
###begin title 13
RNA extraction
###end title 13
###begin p 14
Total RNA was isolated from 7 to 10 10 microm-thick tissue sections per case using the miRdictortrade mark extraction protocol developed at Rosetta Genomics (Rehovot, Israel). Briefly, the sample was incubated a few times in xylene at 57degreesC to remove excess paraffin, and then was washed several times with ethanol. Proteins were degraded by incubating the sample in a proteinase K solution at 45degreesC for a few hours. The RNA was extracted using acid phenol/chloroform and then precipitated using ethanol; DNAses were introduced to digest DNA. Total RNA quantity and quality was measured by Nanodroptrade mark ND-1000 (NanoDrop Technologies, Wilmington, DE).
###end p 14
###begin p 15
###xml 0 10 0 10 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figures S1</xref>
###xml 15 17 15 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">S2</xref>
Figures S1 and S2 in Supplementary Information online demonstrate the reliability of the RNA extraction protocols.
###end p 15
###begin title 16
miRdicatortrade mark array platform
###end title 16
###begin p 17
###xml 66 70 66 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">(21)</xref>
Custom microRNA microarrays were prepared as described previously (21). Briefly on Slide E coated microarray slides (Schott Nexterion, Mainz, Germany) approximately650 DNA oligonucleotide probes representing microRNAs (Sanger database version 9 and additional microRNAs predicted and validated by Rosetta Genomics) were spotted in triplicate using the BioRobotics MicroGrid II microarrater (Genomic Solutions, Ann Arbor, MI) according to the manufacturer's directions. Fifty-four negative control probes were designed using the sense sequences of different microRNAs. Two types of positive control were included in the experimental design: (i) synthetic small RNAs were spiked into each RNA sample before labeling to verify labeling efficiency; and (ii) probes for abundant small RNAs were spotted on the miRdicatortrade mark array to validate RNA quality.
###end p 17
###begin p 18
###xml 479 488 465 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figure S3</xref>
A total of 3.5 microg of total RNA were labeled by ligation of an RNA-linker, p-rCrU-Cy/dye (Dharmacon, Lafayette, CO; Cy3 or Cy5) to the 3' end. Slides were incubated with the labeled RNA for 12-16 h at 42degreesC and then washed twice. Arrays were scanned using Agilent DNA Microarray Scanner Bundle (Agilent Technologies, Santa Clara, CA) at a resolution of 10 microm at 100% power. Array images were analyzed using SpotReader software (Niles Scientific, Portola Valley, CA). Figure S3 demonstrates the reproducibility, sensitivity and specificity of the miRdicatortrade mark microRNA microarray platform.
###end p 18
###begin p 19
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">(21)</xref>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</italic>
###xml 430 431 430 431 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 429 431 429 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S<sup>k</sup></italic>
###xml 458 459 458 459 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 457 459 457 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F<sup>k</sup></italic>
###xml 558 559 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">R</italic>
###xml 575 576 563 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 574 576 562 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F<sup>k</sup></italic>
###xml 578 579 566 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 577 579 565 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S<sup>k</sup></italic>
###xml 656 657 644 645 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 712 713 700 701 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 711 713 699 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">S<sup>k</sup></italic>
###xml 838 839 826 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">k</sup>
###xml 837 839 825 827 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F<sup>k</sup></italic>
###xml 1109 1117 1097 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">Table S1</xref>
Microarray spots were combined and signals normalized as described previously (21). Triplicate spots were combined into one signal by taking the logarithmic mean of the reliable spots. All data were log-transformed and the analysis was performed in log-space. A reference data vector for normalization, R, was calculated by taking the median expression level for each probe across all samples. For each sample k with data vector Sk, a 2nd degree polynomial Fk was found so as to provide the best fit between the sample data and the reference data, such that R approximately Fk(Sk). Remote data points ("outliers") were not used for fitting the polynomials F. For each probe in the sample (element in the vector Sk), the normalized value (in log-space) is calculated from the initial value by transforming it with the polynomial function Fk, so that . Data is translated back to linear-space by taking the exponent. Henceforth, the expression level or signal of a microRNA refers to the normalized value. Values of normalized expression for each sample for the microRNAs examined in the study are available in Table S1 in Supplementary Information online.
###end p 19
###begin title 20
qRT-PCR
###end title 20
###begin p 21
###xml 86 90 82 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">(25)</xref>
###xml 895 896 867 868 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 894 896 866 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>t</sub></italic>
###xml 923 924 895 896 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 958 966 930 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Table S2</xref>
###xml 1021 1022 993 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1051 1052 1023 1024 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1071 1075 1043 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">(28)</xref>
###xml 1082 1083 1054 1055 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1117 1118 1089 1090 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
One microg of total RNA was subjected to polyadenylation reaction as described before (25). Briefly, RNA was incubated in the presence of poly (A) polymerase (Takara-2180A), MnCl2 and ATP for 1 h at 37degreesC. Reverse transcription was performed on the polyadenylated product. An oligo-dT primer harboring a consensus sequence (complementary to the reverse primer) was used for reverse transcription reaction. The primer is first annealed to the poly A-RNA and then subjected to a reverse transcription reaction of SuperScript II RT (Invitrogen). The cDNA was then amplified by real-time PCR reaction, using a miRNA-specific forward primer, TaqMan probe and universal reverse primer. The reactions were incubated for 10 minutes at 95degreesC, followed by 42 cycles of 95degreesC for 15 s and 60degreesC for 1 minute in Applied Biosystems 7500 thermocyclers. Values of cycle to pass threshold (Ct), representing inverse log2 expression levels, are listed in Table S2 in Supplementary Information online. Normalizing the Ct values (per sample) by the Ct of either U6 snRNA(28), the Ct of hsa-miR-24, or their average Ct, shifted at most one sample from each side in the test-set classification predictions.
###end p 21
###begin title 22
Data analysis and statistics
###end title 22
###begin p 23
###xml 244 251 244 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 444 445 444 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 512 513 500 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 548 555 536 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 573 574 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 583 584 571 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 620 621 608 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 928 937 916 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figure S5</xref>
In order to identify microRNA signatures that can be used to differentiate primary brain tumors from brain metastases, we compared the brain primary tumor samples to other primary tumors and to the brain metastases using statistical tests (see Table 2). P-values were calculated using a two-sided t-test on the log-transformed normalized signal. After adjustment for false detection rate or the more strict Bonferroni correction (multiply each P-value by the number of microRNAs tested, approximately1000), most P-values remain highly significant (Table 2 lists unadjusted P-values; P-values are mostly below 1e-8). The t-test is designed to identify differences in the distribution mean, but is not an ideal tool to develop classifiers. We used the area under curve (AUC) of the response operating characteristic (ROC) curve to identify microRNA and microRNA combinations that could be used to classify samples accurately (see Figure S5). The receiver operating characteristic curve (ROC curve) plots the sensitivity against the false-positive rate (one minus the specificity) for different cutoff values of a diagnostic metric, and is a measure of classification performance. The area under the ROC curve, or AUC, can be used to assess the diagnostic performance of a metric. A random classifier has AUC = 0.5, and an optimal classifier with perfect sensitivity and specificity of 100% has AUC = 1.
###end p 23
###begin p 24
Comparison between microRNA expression in primary brain tumors and expression in other primary tumors or expression in brain metastases, based on microRNA microarray data. Abbreviation: AUC = area under curve.
###end p 24
###begin p 25
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 60 61 60 61 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 59 61 59 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 67 68 67 68 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 66 68 66 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 245 246 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
P-values are calculated on log-signal of microRNAs, and on C0 and C1 (methods), which are in log-space. Less that 1000 probes were tested, and even after the more severe Bonferroni correction (multiplying each P-value by approximately1000), the P-values remain highly significant.
###end p 25
###begin p 26
The fold change is calculated by dividing the median signal in brain primary tumors by the median signal in other tissues.
###end p 26
###begin p 27
###xml 21 22 21 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 20 22 20 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 52 53 52 53 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 124 125 124 125 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 123 125 123 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 145 146 132 133 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 172 173 159 160 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 372 381 359 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figure S5</xref>
###xml 434 435 421 422 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 433 435 420 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 465 466 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 533 534 520 521 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 532 534 519 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 554 555 528 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 580 581 554 555 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 741 742 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 740 742 714 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 748 749 722 723 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 747 749 721 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 780 788 754 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">Table S1</xref>
The combined metric C0 was defined as the summed log2 expression measured by microarray of hsa-miR-124 and hsa-miR-219-5p: C0 identical with [log2(hsa-miR-124 signal) + log2(hsa-miR-219-5p signal)], and had AUC = 1 when used to identify primary brain tumors from other primary tumors, but had AUC = 0.8987 when used to identify brain primary tumors from brain metastases (Figure S5 in Supplementary Information). The combined metric C1 was defined as the summed log2 expression measured by microarray of hsa-miR-9* and hsa-miR-92b: C1 identical with [log2(hsa-miR-9* signal) + log2(hsa-miR-92b signal)], and had AUC = 1 when used to identify primary brain tumors from other primary tumors or from brain metastases. The calculated values of C0 and C1 for each sample are listed in Table S1 in Supplementary Information online.
###end p 27
###begin p 28
###xml 21 23 21 23 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT</sup></italic>
###xml 53 54 53 54 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 104 105 104 105 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 145 147 145 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT</sup></italic>
###xml 171 172 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 187 188 174 175 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 399 402 386 389 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT*</sup>
###xml 398 402 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT*</sup></italic>
###xml 438 439 425 426 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 479 482 466 469 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT*</sup>
###xml 478 482 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT*</sup></italic>
###xml 506 507 480 481 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 523 524 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 740 742 714 716 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
###xml 739 742 713 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT</sup></italic>
###xml 748 751 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT*</sup>
###xml 747 751 721 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT*</sup></italic>
###xml 782 790 756 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD3">Table S2</xref>
The combined metric CRT was defined as the summed log2 expression levels measured by qRT-PCR data (the Ct values) of hsa-miR-9 and hsa-miR-92b: CRT identical with 100 - [Ct(hsa-miR-9) + Ct(hsa-miR-92b signal)], had AUC = 1 in the training set data and one error in the test-set data when used to identify primary brain tumors from other primary tumors or from brain metastases. The combined metric CRT* was defined as the summed qRT-PCR Ct values of hsa-miR-9* and hsa-miR-92b: CRT* identical with 100 - [Ct(hsa-miR-9*) + Ct(hsa-miR-92b signal)], had AUC = 1 in the training set data and one error in the test-set data when used to identify primary brain tumors from other primary tumors or from brain metastases. The calculated values of CRT and CRT* for each sample are listed in Table S2 in Supplementary Information online.
###end p 28
###begin title 29
RESULTS
###end title 29
###begin p 30
###xml 225 232 225 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 247 255 247 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">Table S1</xref>
###xml 414 421 414 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 496 500 496 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">(14)</xref>
###xml 650 651 638 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 687 694 675 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 759 760 747 748 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 758 760 746 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 875 884 863 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 890 898 878 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">Table S1</xref>
###xml 1092 1093 1080 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1127 1137 1115 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figure S4A</xref>
###xml 1554 1558 1542 1546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">(14)</xref>
###xml 1631 1640 1619 1628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
###xml 1911 1918 1887 1894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1923 1932 1899 1908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figure S5</xref>
We profiled microRNA expression levels on a microarray platform in 252 tumor samples including 15 brain primary tumor samples, 187 non-brain primary tumors, and 50 brain metastases from various tissue origins (see summary in Table 1 and detail in Table S1 in Supporting Information online). We compared the brain primary tumor samples to the other primary tumor samples and to samples of brain-located metastases (Table 2 and methods). Hsa-miR-124, which is highly specific to the nervous system (14), displayed the greatest disparity in expression when comparing brain primary tumors to other primary tumors, with a fold-change of approximately100 (P-value = 5.1e-57, AUC = 0.9976, see Table 2 and Methods). A combination of hsa-miR-124 and hsa-miR-219-5p (C0, see methods) could be used to distinguish brain primary tumors from non-brain primary tumors with 100% accuracy (Figure 1A, see Table S1 in Supporting Information for values). Other brain-specific microRNAs such as hsa-miR-128 also showed very strong differential expression between brain primary tumors and other primary tumors (P-value < 4e-28, AUC = 0.9932, see Figure S4A in Supporting Information online). In extracting and profiling microRNA from bulk tissue samples, the measured RNA sample contains RNA from the tumor cells, but also RNA from the surrounding tissue. In our study, more than 90% of the samples had a tumor content of at least 50%; nevertheless, a fair amount of non-tumor cells are present in the specimens. These microRNAs, which are highly expressed in normal brain (14), were also found at high levels in RNA extracted from brain metastases (Figure 1A). This latter effect, ostensibly caused by contamination from the adjacent normal brain tissue, limits the utility of these microRNAs to serve as biomarkers for differentiating between brain primary tumors and brain-located metastases (AUC of 0.85approximately0.95, see Table 2 and Figure S5).
###end p 30
###begin p 31
###xml 0 72 0 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Identification of metastatic brain tumors using microRNA microarray data</italic>
###xml 74 76 74 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 484 485 484 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 483 485 483 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 505 506 492 493 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 525 526 512 513 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 766 768 753 755 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 979 980 966 967 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 978 980 965 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 1000 1001 974 975 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1019 1020 993 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1251 1252 1225 1226 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1250 1252 1224 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 1276 1277 1250 1251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1275 1277 1249 1251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
Identification of metastatic brain tumors using microRNA microarray data. A. Expression levels of hsa-miR-124 and hsa-miR-219-5p in 15 brain primary tumors (blue/cyan squares), 187 primary tumors from other tissues (black/yellow diamonds) and 50 brain metastases originating from various tissues (green circles). Expression levels of hsa-miR-124 and hsa-miR-219-5p are higher in brain primary tumors compared to primary tumors from other tissues. The solid line marks the line where C0 identical with [log2(hsa-miR-124) + log2(hsa-miR-219-5p)] = 16.8, and provides perfect separation between brain primary and other primary tumors. The expression levels of hsa-miR-124 and hsa-miR-219-5p in metastatic samples span a wide range on both sides of the separating line. B. Expression levels of hsa-miR-9* and hsa-miR-92b in the same samples. Expression levels of these microRNAs are high in brain primary tumors but are low in all other samples. The solid line marks the line where C1 identical with [log2(hsa-miR-9*) + log2(hsa-miR-92b)] = 19, and provides perfect separation between brain primary tumors and other samples, including other primary tumors and metastases to the brain. The dashed lines mark a confidence range of factor 2 above or below, C1 = 20 (upper line) and C1 = 18 (lower line). Only two of the samples (<1%) fall within the low-confidence range.
###end p 31
###begin p 32
###xml 218 227 218 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1B</xref>
###xml 232 239 232 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 390 391 390 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 500 501 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 499 501 499 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 640 649 640 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1B</xref>
###xml 654 661 654 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 725 726 725 726 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 724 726 724 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 755 756 755 756 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 754 756 754 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 1030 1031 1028 1029 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1029 1031 1027 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 1060 1061 1058 1059 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1059 1061 1057 1059 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 1098 1099 1094 1095 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 1097 1099 1093 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>1</sub></italic>
###xml 1165 1174 1159 1168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1B</xref>
###xml 1180 1188 1174 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD2">Table S1</xref>
We observed that in addition to the aforementioned microRNAs (hsa-miR-124, hsa-miR-219-5p and hsa-miR-128), hsa-miR-9* and hsa-miR-92b are expressed specifically in brain tumors and not expressed in other tumor types (Figure 1B and Table 2: AUC > 0.99). Importantly, these two microRNAs also differentiate accurately between brain primary tumors and metastatic tumors located in the brain (P-value < 3e-18, AUC > 0.99 for each). Indeed, using a combination of hsa-miR-9* and hsa-miR-92b expression (C1, see methods) it is possible to distinguish brain primary tumor samples from all other samples with 100% accuracy in the microarray data (Figure 1B and Table 2). A simple decision rule, "classify as primary brain tumor if C1 > 19, classify as other if C1 </= 19," identifies correctly all samples. A more conservative classifier can be defined by allowing a margin for uncertainty of factor 2 above or below the threshold (equivalent to one cycle in qRT-PCR measurements). The classification rule "classify as brain primary if C1 > 20, classify as other if C1 < 18, leave unidentified if 18 </= C1</= 20" leaves only two samples out of 252 (<1%) as unclassified (Figure 1B, see Table S1), and classifies correctly all other samples.
###end p 32
###begin p 33
###xml 98 106 98 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD3">Table S2</xref>
###xml 192 199 192 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
###xml 563 572 563 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2A</xref>
###xml 851 859 851 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2</xref>
###xml 966 973 966 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
To validate these findings, we profiled 14 of these samples and 33 additional samples by qRT-PCR (Table S2), for four potential biomarkers: hsa-miR-124, hsa-miR-9, hsa-miR-9* and hsa-miR-92b (Table 3), and two controls: hsa-miR-24, which was found to be relatively constantly expressed in the microarray data, and snRNA U6. These microRNAs showed the same pattern as observed in the microarray data (Table 3). Hsa-miR-124 showed strong expression in the brain primary tumors, weak expression in other primary tumors and intermediate expression in the metastases (Figure 2A). Thus, hsa-miR-124 was not a good candidate for identifying metastatic tumors to the brain. On the other hand, hsa-miR-9, hsa-miR-9* and hsa-miR-92b showed specific strong expression in primary brain tumors with lower expression in other tumors and in metastases to the brain (Figure 2), with significant differences and strong separability between brain primary tumors and brain metastases (Table 3).
###end p 33
###begin p 34
Comparison between microRNA expression in primary brain tumors and expression in other primary tumors or expression in brain metastases, based on microRNA qRT-PCR data. Abbreviation: AUC = area under curve.
###end p 34
###begin p 35
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 37 38 37 38 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 54 56 54 56 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
###xml 62 64 62 64 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
P-values are calculated on measured Ct values and on CRT and CRT* (methods), which are in log-space. Here only the listed four potential biomarkers and two combinations were tested, and no correction for multiple hypothesis testing is needed.
###end p 35
###begin p 36
The fold change is calculated by converting the data to linear space (by taking the exponent base 2) and dividing the median signal in brain primary tumors by the median signal in other tissues.
###end p 36
###begin p 37
###xml 0 69 0 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Identification of metastatic brain tumors using microRNA qRT-PCR data</italic>
###xml 71 73 71 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 97 98 97 98 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 671 673 671 673 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 697 698 697 698 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 875 878 875 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT*</sup>
###xml 874 878 874 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT*</sup></italic>
###xml 900 901 887 888 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 917 918 904 905 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1134 1135 1121 1122 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1167 1168 1154 1155 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 1183 1184 1170 1171 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
Identification of metastatic brain tumors using microRNA qRT-PCR data. A. Expression levels (50-Ct) of hsa-miR-124 and hsa-miR-9 in 16 brain primary tumors (blue/cyan squares), 15 primary tumors from other tissues (black/yellow diamonds) and 16 brain metastases originating from various tissues (green circles). Expression levels of hsa-miR-124 and hsa-miR-9 are higher in brain primary tumors compared to primary tumors from other tissues. The expression levels of hsa-miR-124 in metastatic samples span a wide range and are more similar to brain primary tumors; the expression levels of hsa-miR-9 in metastatic samples are more similar to the non-brain primary tumors. B. Expression levels (50-Ct) of hsa-miR-9* and hsa-miR-92b in the same samples. Expression levels of these microRNAs are high in brain primary tumors and lower in all other samples. The solid line marks CRT* identical with 100-[Ct(hsa-miR-9*) + Ct(hsa-miR-92b)] = 39.9, a threshold that was fit to the training set half of the data. The test-set samples (symbols with red outline) were accurately classified by this threshold, with one outlier. Data points with Ct larger than 40 are shown with Ct = 40, at (50-Ct) = 10.
###end p 37
###begin p 38
###xml 63 65 63 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
###xml 62 65 62 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT</sup></italic>
###xml 88 91 88 91 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT*</sup>
###xml 87 91 87 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT*</sup></italic>
###xml 119 120 119 120 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</sub>
###xml 653 656 653 656 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT*</sup>
###xml 652 656 652 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT*</sup></italic>
###xml 658 667 658 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig02">Figure 2B</xref>
###xml 674 676 674 676 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
###xml 673 676 673 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sup>RT</sup></italic>
###xml 678 686 678 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD3">Table S2</xref>
###xml 826 833 826 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl3">Table 3</xref>
We defined combinations of hsa-miR-92b with either hsa-miR-9 (CRT) or with hsa-miR-9* (CRT*) by summing their qRT-PCR Ct values (see Methods). We selected a threshold for classification for each combination using half of the samples as a training set. We then tested the classification accuracy on the second half of the data set that was used as a test-set. The classifications on the test-set were near perfect with one outlier of 23 samples, reaching 100% accuracy in identifying non-brain primary tumors from brain primary tumors, and 88% sensitivity with 100% specificity in identifying metastatic brain tumors from brain primary tumors, for both CRT* (Figure 2B) and CRT (Table S2). Indeed, these combinations show significant differences in expression that can be used to classify primary from metastatic brain tumors (Table 3).
###end p 38
###begin p 39
According to these data, we propose that hsa-miR-9/9* and hsa-miR-92b, and their combination, represent new biomarkers that can be used to classify brain malignancies-primary vs. secondary.
###end p 39
###begin p 40
###xml 130 134 130 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">(14)</xref>
###xml 218 220 218 220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 513 516 513 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">(9)</xref>
###xml 613 623 613 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="SD1">Figure S4C</xref>
###xml 281 286 <span type="species:ncbi:9606">human</span>
Hsa-miR-92b and hsa-miR-9/9* were reported previously to be expressed in brain tumors and in cell lines derived from brain tumors (14) and were documented to be expressed specifically in the developing nervous system (12, 13, 32, 34). The gene encoding hsa-miR-9/9* appears in the human genome in three places, in chromosomes 1, 5 and 14, each an identical copy. Hsa-miR-92b is found on chromosome 1 and differs by only one nucleotide in its first 20 from hsa-miR-92a, a member of the oncogenic miR-17-92 cluster (9). However, the expression pattern of hsa-miR-92a did not correlate with that of and hsa-miR-92b (Figure S4C) and was not useful in identification between primary and metastatic brain malignancies.
###end p 40
###begin title 41
DISCUSSION
###end title 41
###begin p 42
###xml 302 305 302 305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">(1)</xref>
When faced with a neoplastic brain specimen considered most likely to be a metastasis, a surgical pathologist must always rule out the possibility that it represents a malignant glioma. As a rule, certain morphological features aid in the distinction between secondary and primary neoplasms of the CNS (1). Metastases retain a cohesive quality as they enlarge, and thus remain demarcated from the host tissue, while astrocytic and oligodendroglial tumors exhibit an infiltrative growth pattern, intermingling with the normal cells of the brain tissue. Additionally, in contrast to neoplastic glial cells, neoplastic cells of metastatic carcinomas reveal their epithelial nature by their round or polygonal shape, distinct cellular borders and lack of processes. Furthermore, the amount of fibrous tissue in metastatic lesions is typically greater than in most gliomas, and also, the pattern of necrosis seems to be different in primary tumors from that seen in metastases. However, poorly differentiated metastatic carcinoma may be difficult to distinguish histologically from high-grade astrocytic malignant neoplasms, particularly on small open or stereotactic biopsy specimens.
###end p 42
###begin p 43
###xml 378 382 378 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">(17)</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">(17)</xref>
###xml 787 788 787 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 790 792 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 881 884 881 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">(8)</xref>
###xml 1307 1311 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">(19)</xref>
###xml 1481 1485 1481 1485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">(26)</xref>
###xml 1564 1566 1564 1566 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 1568 1570 1568 1570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 1572 1574 1572 1574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
Immunohistochemical studies are often employed to help in diagnosing brain specimens. One study reported a sensitivity of 100% at a specificity of 86% for identifying primary glioblastoma multiforme (GBM) from metastatic carcinoma using immunohistochemical staining for glial fibrillary acidic protein (GFAP), but a significant number of the metastatic cancers are also stained (17). A combination of immunostains, including GFAP and cytokeratin CAM5.2, has been suggested as useful in differentiating poorly differentiated metastatic carcinoma from GBM (17). However, GBM may variably stain with cytokeratin immunomarkers, usually expressed in epithelial tumors. Co-expression of GFAP and cytokeratin is frequently found, especially in cases of undifferentiated and high grade gliomas (8, 16). Therefore, cytokeratin positivity does not rule out the diagnosis of a glial neoplasm (8). Suggested workup for the differential diagnosis between primary brain neoplasms and poorly differentiated metastatic carcinoma based on immunohistochemistry, therefore, requires a combination of multiple factors, and their accuracy in different scenarios has not yet been established. Regardless of these morphological and immunohistological tools, some neoplastic brain specimens still cannot be definitively classified (19). For instance, anaplastic oligodendroglioma can be macroscopically discrete and composed of compactly arranged polygonal cells such that it simulates a metastatic tumor (26). Despite the progress recently made for molecular evaluation of brain tumors (20, 24, 29), not much data was achieved for the molecular differential diagnosis between primary and metastatic tumors in the brain.
###end p 43
###begin p 44
In this study, we present a new diagnostic tool to aid in the differentiation between primary and secondary neoplasms of the CNS: the combined expression of two specific microRNAs, which serves as a novel "brain primary tumor" biomarker.
###end p 44
###begin p 45
###xml 396 405 396 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig01">Figure 1A</xref>
To find microRNA biomarkers that classify brain tumors, we compared microRNA expression profiles of brain primary tumors, non-brain primary tumors and brain metastases. Initial analyses identified microRNAs, such as hsa-miR-124, that are significantly over-expressed in brain primary tumors compared to non-brain primary tumors, and thus appear to distinguish brain tumors from non-brain tumors (Figure 1A). However, many of these microRNAs are highly expressed in normal brain tissue. Inevitably, during biopsy procedures, significant amounts of normal tissue are excised along with cancerous tissue. In our samples, the tumor content was greater than or equal to 50% in more than 90% of the samples. Nevertheless, as in most studies of expression profiling on tissue samples, a fair amount of non-tumor cells are present in the specimens. Thus, brain-specific microRNAs, such as hsa-miR-124, can be found variously in tissue specimens containing brain metastases, and their expression levels measured in bulk tissue samples do not allow discrimination between brain primary tumors and metastases located in the brain.
###end p 45
###begin p 46
Further analyses, which included a substantial set of 50 brain metastasis samples, delineated a subset of microRNAs that are expressed specifically in brain primary tumors, but importantly, neither in non-brain primary tumors nor in brain-located metastases. Specifically, we found that hsa-miR-92b and hsa-miR-9/9* are very significantly and strongly over-expressed in samples of primary brain tumors, but not in samples of metastatic tumors to the brain. These bulk samples contain surrounding tissue, and it cannot be ruled out at this stage that a fraction of the over-expressed microRNAs may be derived from non-neoplastic glial cells in the surrounding tissue, in which this expression is specific to reactive cells surrounding primary tumors only. Regardless of its biological origin, the specific over-expression of these microRNAs in samples from brain primary tumors provides important diagnostic information. The combined expression levels of hsa-miR-92b and hsa-miR-9/9* allow discrimination between brain primary tumors and metastases located in the brain with very high accuracy, and thus represent a potential biomarker for the identification of brain primary tumors.
###end p 46
###begin p 47
###xml 184 186 184 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b12">12</xref>
###xml 188 190 188 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 455 456 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
Notably, hsa-miR-92b and hsa-miR-9/9* were reported previously to be over-expressed in neuronal-specific stem cells and to exhibit dynamic expression patterns in the developing brain (12, 13, 32, 34). Thus, it appears that elevated expression of these microRNAs is a feature common to brain stem cells and brain tumor cells. Whether cancerous cells originate from abnormal stem cells or represent de-differentiated somatic cells is a hotly debated issue (4, 31). In any case, our data reinforce the enigmatic association between pluripotency and tumorigenesis. Further research should elucidate the function of these microRNAs in the brain and their roles in brain cancer.
###end p 47
###begin title 48
DISCLOSURE
###end title 48
###begin p 49
All authors affiliated with Rosetta Genomics are full-time employees of Rosetta Genomics Ltd. and hold equity in the company, the value of which may be influenced by this publication.
###end p 49
###begin title 50
REFERENCES
###end title 50
###begin article-title 51
###xml 66 69 <span type="species:ncbi:9606">man</span>
Weekly clinicopathological exercises. Case 28-1992. A 45-year-old man with confusion, seizures, and few focal findings
###end article-title 51
###begin article-title 52
###xml 57 62 <span type="species:ncbi:9606">human</span>
Identification of hundreds of conserved and nonconserved human microRNAs
###end article-title 52
###begin article-title 53
###xml 0 6 <span type="species:ncbi:9837|species:ncbi:9838">Camels</span>
###xml 11 20 <span type="species:ncbi:7955">zebrafish</span>
Camels and zebrafish, viruses and cancer: a microRNA update
###end article-title 53
###begin article-title 54
Nuclear cloning of embryonal carcinoma cells
###end article-title 54
###begin article-title 55
Central nervous system metastases in malignant melanoma
###end article-title 55
###begin article-title 56
###xml 23 28 <span type="species:ncbi:9606">human</span>
MicroRNA signatures in human cancers
###end article-title 56
###begin article-title 57
Disposition of cerebral metastases from malignant melanoma: implications for radiosurgery
###end article-title 57
###begin article-title 58
Expression of cytokeratins in gliomas
###end article-title 58
###begin article-title 59
###xml 65 70 <span type="species:ncbi:9606">human</span>
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation
###end article-title 59
###begin article-title 60
Intracranial metastases in small cell carcinoma of the lung: correlation of clinical and autopsy findings
###end article-title 60
###begin article-title 61
How microRNAs choose their targets
###end article-title 61
###begin article-title 62
MicroRNAs show a wide diversity of expression profiles in the developing and mature central nervous system
###end article-title 62
###begin article-title 63
A microRNA array reveals extensive regulation of microRNAs during brain development
###end article-title 63
###begin article-title 64
A mammalian microRNA expression atlas based on small RNA library sequencing
###end article-title 64
###begin article-title 65
###xml 38 43 <span type="species:ncbi:9606">human</span>
MicroRNA expression profiles classify human cancers
###end article-title 65
###begin article-title 66
Cytokeratin immunoreactivity in gliomas
###end article-title 66
###begin article-title 67
Evaluation of epithelial and keratin markers in glioblastoma multiforme: an immunohistochemical study
###end article-title 67
###begin article-title 68
###xml 35 40 <span type="species:ncbi:9606">human</span>
Raising the estimate of functional human sequences
###end article-title 68
###begin article-title 69
Intracranial metastases from systemic cancer
###end article-title 69
###begin article-title 70
###xml 61 66 <span type="species:ncbi:9606">human</span>
Isolation of novel differentially expressed genes related to human glioma using cDNA microarray and characterizations of two novel full-length genes
###end article-title 70
###begin article-title 71
Transcriptional Activation of miR-34a Contributes to p53-Mediated Apoptosis
###end article-title 71
###begin article-title 72
Central nervous system involvement in malignant melanoma
###end article-title 72
###begin article-title 73
MicroRNAs accurately identify cancer tissue origin
###end article-title 73
###begin article-title 74
Gene expression profile analysis of primary glioblastomas and non-neoplastic brain tissue: identification of potential target genes by oligonucleotide microarray and real-time quantitative PCR
###end article-title 74
###begin article-title 75
Facile means for quantifying microRNA expression by real-time PCR
###end article-title 75
###begin article-title 76
Tumors of the Uterine Corpus and Gestational Trophoblastic Disease
###end article-title 76
###begin article-title 77
MicroRNAs in disease and potential therapeutic applications
###end article-title 77
###begin article-title 78
Extensive post-transcriptional regulation of microRNAs and its implications for cancer
###end article-title 78
###begin article-title 79
Primary glioblastomas express mesenchymal stem-like properties
###end article-title 79
###begin article-title 80
Central nervous system metastasis from breast carcinoma. Autopsy study
###end article-title 80
###begin article-title 81
DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal
###end article-title 81
###begin article-title 82
###xml 46 53 <span type="species:ncbi:8355">Xenopus</span>
Stage-specific expression of microRNAs during Xenopus development
###end article-title 82
###begin article-title 83
Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples
###end article-title 83
###begin article-title 84
###xml 34 39 <span type="species:ncbi:9606">human</span>
Genome-wide microRNA profiling in human fetal nervous tissues by oligonucleotide microarray
###end article-title 84
###begin title 85
SUPPLEMENTARY MATERIAL
###end title 85
###begin p 86
The following supplementary material is available for this article:
###end p 86
###begin p 87
###xml 0 13 0 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S1. A.</bold>
###xml 134 135 133 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 187 188 186 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 299 301 298 300 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 395 396 394 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
###xml 452 453 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">y</italic>
###xml 70 75 <span type="species:ncbi:10090">mouse</span>
Figure S1. A. RNA was extracted and profiled (4 mug total RNA) from a mouse liver sample, which was either preserved as fresh frozen (y-axis) or formalin-fixed, paraffin-embedded (FFPE) (x-axis). Overall correlation of expressions was 0.9. Similar results were obtained for RNA extracted from lung. B. Similar results were obtained when comparing microRNA expression extracted from FFPE sample (x-axis) to the RNA extracted from formalin-fixed sample (y-axis). Overall correlation of expressions was 0.9. Similar results were obtained for RNA extracted from lung. We next examined the difference in the level of microRNA expression in tissues (liver and lung) preserved at different time points, immediate, 1 h and 5 h post-operation. The microRNA fraction in the lung was not affected even when kept non-fixed for 5 h. Delaying fixation of a liver sample by 1 h had no significant change on the microRNA fraction, but the microRNA fraction was decreased approximately twofold when the liver sample was kept non-fixed for 5 h, reflecting the high content of nucleases in liver tissue (data not shown).
###end p 87
###begin p 88
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S2.</bold>
###xml 404 405 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">x</italic>
Figure S2. MicroRNA stability in formalin-fixed, paraffinembedded (FFPE) archival samples of different ages: total RNA was extracted from 13 lung FFPE samples of different ages (ages 2-11 years) and hybridized to the miRdicatortrade mark microarray. Each bar in the graph depicts the overall microRNA expression correlation (Pearson correlation coefficient) between a single sample (age appearing on the x-axis), and the newest sample (age 2 years). The high correlation (mostly above 0.9) indicates the highly preserved fraction of microRNA in paraffin blocks even after many years.
###end p 88
###begin p 89
###xml 0 13 0 13 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S3. A.</bold>
###xml 422 424 421 423 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 770 772 768 770 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 1439 1441 1428 1430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</bold>
Figure S3. A. Microarray reproducibility: 3 mug of placenta RNA (Ambion) was repeatedly (seven times) labeled and hybridized to the microarray. For >200 highly expressed microRNAs (sorted from top to bottom by mean expression level), each column depicts the expression in one repeat. For each pair of repeats, the Pearson correlation coefficient was computed, resulting in an overall mean correlation coefficient of 0.99. B. Microarray sensitivity and dynamic range: four synthetic short RNAs, 22 nt long, were spiked in different amounts into 3 mug of placenta total RNA, labeled and hybridized to the array. Each line corresponds to one of the spike-ins. The lowest sensitivity was found to be 0.1 fmole with a linear dynamic range of about three orders of magnitude. C. Microarray specificity: synthetic RNAs of hsalet- 7a, c and d were spiked into non-relevant background material (high molecular weight RNA extracted from HeLa cell line, which shows no hybridization background when hybridized to the microarray, data not shown) and hybridized to the miRdicatortrade mark microarray. The table depicts the probe signals of the let-7 family in response to the spiked-in synthetic RNAs (columns), normalized by the signal of the probe corresponding to the synthetic RNA. Specificity of about 10-fold in the signal level between let-7a and let-7c was demonstrated, representing the level of specificity for a single nucleotide mismatch. D. Tissue specificity: 3-5 mug of total RNA extracted from liver and testis formalinfixed, paraffin-embedded samples were labeled and hybridized to the miRdicatortrade mark microarray, identifying tissue specific microRNA expression profiles such as hsa-miR-122a in the liver and hsa-miR-372 and hsa-miR-373 in the testis tissue.
###end p 89
###begin p 90
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S4.</bold>
###xml 10 235 10 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression levels of microRNA (microarray data) in 15 primary brain tumors (blue/cyan squares), 187 primary tumors from other tissues (black/yellow diamonds) and 50 brain metastases from various tissue origins (green circles)</italic>
###xml 237 239 237 239 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl2">Table 2</xref>
###xml 570 572 570 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 930 932 930 932 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
Figure S4.Expression levels of microRNA (microarray data) in 15 primary brain tumors (blue/cyan squares), 187 primary tumors from other tissues (black/yellow diamonds) and 50 brain metastases from various tissue origins (green circles). A. HsamiR-128 has high expression levels in brain primary tumors, low in other primary tumors and intermediate in brain metastasis samples (see Table 2). In contrast to hsa-miR-128, hsa-miR-92b is specifically expressed in brain primary tumors, and is lower in primary tumors from other tissues and in their metastases to the brain. B. Hsa-miR-124 has high expression levels in brain primary tumors, low in other primary tumors, and its expression levels in RNA extracted from brain metastasis samples spans a wide range. In contrast to hsa-miR-124, hsa-miR-9* is specifically expressed in brain primary tumors, and is lower in primary tumors from other tissues and in their brain metastases. C. Expression of hsa-miR-92a did not correlate with expression of hsa-miR-92b and was not useful for identification between primary and metastatic brain malignancies.
###end p 90
###begin p 91
###xml 0 10 0 10 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Figure S5.</bold>
###xml 10 482 10 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">The receiver operating characteristic curve (ROC curve) plots the sensitivity against the false-positive rate (one minus the specificity) for different cutoff values of a diagnostic metric, and is a measure of classification performance. The area under the ROC curve [area under curve(AUC)] can be used to asses the diagnostic performance of metric. A random classifier has AUC = 0.5, and an optimal classifier with perfect sensitivity and specificity of 100% has AUC = 1.</italic>
###xml 482 484 482 484 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A.</bold>
###xml 507 508 507 508 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 506 508 506 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 645 646 645 646 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 644 646 644 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 743 745 743 745 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B.</bold>
###xml 765 766 765 766 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 764 766 764 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 804 806 804 806 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C.</bold>
###xml 829 830 829 830 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 828 830 828 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 958 959 958 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 957 959 957 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
###xml 1061 1063 1061 1063 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D.</italic>
###xml 1083 1084 1083 1084 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 1082 1084 1082 1084 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C<sub>0</sub></italic>
Figure S5.The receiver operating characteristic curve (ROC curve) plots the sensitivity against the false-positive rate (one minus the specificity) for different cutoff values of a diagnostic metric, and is a measure of classification performance. The area under the ROC curve [area under curve(AUC)] can be used to asses the diagnostic performance of metric. A random classifier has AUC = 0.5, and an optimal classifier with perfect sensitivity and specificity of 100% has AUC = 1.A. The sorted values of C0 for 15 samples of brain primary tumors (blue squares) and 187 samples of non-brain primary tumors (red circles). The dashed line shows C0 = 16.8, which perfectly separates these two sets of samples (sensitivity = specificity = 100%). B. The ROC curve for C0 in these samples, which has AUC = 1. C. The sorted values of C0 for 15 samples of brain primary tumors (blue squares) and 50 samples of brain metastases (red circles). The dashed line shows C0 = 16.8, which misclassifies 20 of the 50 metastasis samples (sensitivity = 60%, specificity = 100%). D. The ROC curve for C0 in these samples, which has AUC = 0.8987.
###end p 91
###begin p 92
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S1.</bold>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 141 142 141 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Table S1. Details for the 252 samples measured by microarray, expression levels of microRNAs used in the study, and combined metrics C0 and C1.
###end p 92
###begin p 93
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Table S2.</bold>
###xml 130 132 130 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT</sup>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RT*</sup>
Table S2. Details for the 47 samples measured by qRT-PCR, expression levels of microRNAs used in the study, and combined metrics CRT and CRT*.
###end p 93
###begin p 94
This material is available as part of the online article from:
###end p 94
###begin p 95
Please note: Blackwell Publishing is not responsible for the content or functionality of any supplementary materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.
###end p 95

